152 related articles for article (PubMed ID: 9625444)
1. Expression of fibroblast growth factor-2 and fibroblast growth factor receptor-1 in thyroid diseases: difference between neoplasms and hyperplastic lesions.
Shingu K; Fujimori M; Ito K; Hama Y; Kasuga Y; Kobayashi S; Itoh N; Amano J
Endocr J; 1998 Feb; 45(1):35-43. PubMed ID: 9625444
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical localization of acidic and basic fibroblast growth factors in human benign and malignant thyroid lesions.
Kodama M; Daa T; Kashima K; Yokoyama S; Nakayama I; Noguchi S
Jpn J Clin Oncol; 1994 Apr; 24(2):66-73. PubMed ID: 7512670
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factors 1 and 2 and fibroblast growth factor receptor 1 are elevated in thyroid hyperplasia.
Thompson SD; Franklyn JA; Watkinson JC; Verhaeg JM; Sheppard MC; Eggo MC
J Clin Endocrinol Metab; 1998 Apr; 83(4):1336-41. PubMed ID: 9543164
[TBL] [Abstract][Full Text] [Related]
4. Expression of fibroblast growth factors in thyroid cancer.
Eggo MC; Hopkins JM; Franklyn JA; Johnson GD; Sanders DS; Sheppard MC
J Clin Endocrinol Metab; 1995 Mar; 80(3):1006-11. PubMed ID: 7533768
[TBL] [Abstract][Full Text] [Related]
5. Expression of basic fibroblast growth factor in thyroid disorders.
Shingu K; Sugenoya A; Itoh N; Kato R
World J Surg; 1994; 18(4):500-5. PubMed ID: 7725735
[TBL] [Abstract][Full Text] [Related]
6. The expression and localization of fibroblast growth factor-1 (FGF-1) and FGF receptor-1 (FGFR-1) in human breast cancer.
Yoshimura N; Sano H; Hashiramoto A; Yamada R; Nakajima H; Kondo M; Oka T
Clin Immunol Immunopathol; 1998 Oct; 89(1):28-34. PubMed ID: 9756721
[TBL] [Abstract][Full Text] [Related]
7. [Immunohistochemical study of epidermal growth factor receptor and estrogen receptor in human thyroid tumors].
Yane K; Tanaka O; Miyahara H; Matsunaga T; Kitahori Y; Hiasa Y
Nihon Jibiinkoka Gakkai Kaiho; 1993 May; 96(5):787-90. PubMed ID: 8315535
[TBL] [Abstract][Full Text] [Related]
8. EGF-receptors in human normal and pathological thyroid tissue.
Westermark K; Lundqvist M; Wallin G; Dahlman T; Hacker GW; Heldin NE; Grimelius L
Histopathology; 1996 Mar; 28(3):221-7. PubMed ID: 8729040
[TBL] [Abstract][Full Text] [Related]
9. Changes in the immunohistochemical localisation of fibroblast growth factor-2, transforming growth factor-beta 1 and thrombospondin-1 are associated with early angiogenic events in the hyperplastic rat thyroid.
Patel VA; Hill DJ; Eggo MC; Sheppard MC; Becks GP; Logan A
J Endocrinol; 1996 Mar; 148(3):485-99. PubMed ID: 8778227
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical localization of growth factors fibroblast growth factor-1 and fibroblast growth factor-2 and receptors fibroblast growth factor receptor-2 and fibroblast growth factor receptor-3 in normal oral epithelium, epithelial dysplasias, and squamous cell carcinoma.
Wakulich C; Jackson-Boeters L; Daley TD; Wysocki GP
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 May; 93(5):573-9. PubMed ID: 12075207
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical demonstration of epidermal growth factor receptor and ceruloplasmin in thyroid diseases.
Song B
Acta Pathol Jpn; 1991 May; 41(5):336-43. PubMed ID: 1867098
[TBL] [Abstract][Full Text] [Related]
12. [HBME-1 immunostaining in thyroid pathology].
Rigau V; Martel B; Evrard C; Rousselot P; Galateau-Salle F
Ann Pathol; 2001 Feb; 21(1):15-20. PubMed ID: 11223556
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptors (alpha and beta) and 17beta-hydroxysteroid dehydrogenase type 1 and 2 in thyroid disorders: possible in situ estrogen synthesis and actions.
Kawabata W; Suzuki T; Moriya T; Fujimori K; Naganuma H; Inoue S; Kinouchi Y; Kameyama K; Takami H; Shimosegawa T; Sasano H
Mod Pathol; 2003 May; 16(5):437-44. PubMed ID: 12748250
[TBL] [Abstract][Full Text] [Related]
14. Increase of basic fibroblast growth factor (FGF) and FGF receptor messenger RNA during rat thyroid hyperplasia: temporal changes and cellular distribution.
Becks GP; Logan A; Phillips ID; Wang JF; Smith C; DeSousa D; Hill DJ
J Endocrinol; 1994 Aug; 142(2):325-38. PubMed ID: 7931005
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor receptors as molecular targets in thyroid carcinoma.
St Bernard R; Zheng L; Liu W; Winer D; Asa SL; Ezzat S
Endocrinology; 2005 Mar; 146(3):1145-53. PubMed ID: 15564323
[TBL] [Abstract][Full Text] [Related]
16. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.
Chiappetta G; Tallini G; De Biasio MC; Manfioletti G; Martinez-Tello FJ; Pentimalli F; de Nigris F; Mastro A; Botti G; Fedele M; Berger N; Santoro M; Giancotti V; Fusco A
Cancer Res; 1998 Sep; 58(18):4193-8. PubMed ID: 9751634
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical demonstration of thyrotropin (TSH)-receptor in normal and diseased human thyroid tissues using monoclonal antibody against recombinant human TSH-receptor protein.
Mizukami Y; Hashimoto T; Nonomura A; Michigishi T; Nakamura S; Noguchi M; Matsukawa S
J Clin Endocrinol Metab; 1994 Aug; 79(2):616-9. PubMed ID: 8045985
[TBL] [Abstract][Full Text] [Related]
18. [Expression of cytokeratin19, galectin-3 and HBME-1 in thyroid lesions and their differential diagnoses].
Teng XD; Wang LJ; Yao HT; Li J; Ding W; Yan LP
Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):212-6. PubMed ID: 15256110
[TBL] [Abstract][Full Text] [Related]
19. Galectin-3 messenger ribonucleic acid and protein are expressed in benign thyroid tumors.
Martins L; Matsuo SE; Ebina KN; Kulcsar MA; Friguglietti CU; Kimura ET
J Clin Endocrinol Metab; 2002 Oct; 87(10):4806-10. PubMed ID: 12364477
[TBL] [Abstract][Full Text] [Related]
20. Basic fibroblast growth factor: an autocrine mitogen of rat thyroid follicular cells?
Logan A; Black EG; Gonzalez AM; Buscaglia M; Sheppard MC
Endocrinology; 1992 Apr; 130(4):2363-72. PubMed ID: 1312454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
